by PierianDx, on December 11, 2019
Intermountain Healthcare joins PierianDx’s partner network to accelerate precision medicine
Read Storyby PierianDx, on October 28, 2019
Funding led by ATW Partners and SJF Ventures with follow-on Investment from Health Catalyst Capital, RTI International, and Inova Health Systems
Read Storyby PierianDx, on January 4, 2019
Comprehensive pan-cancer tumor profiling assays to be combined with clinical informatics platform with the potential to reduce time, cost, and complexity of clinical genomic analysis
Read Storyby Josh Forsythe, on June 11, 2018
PierianDx, the leading clinical genomics technology company that enables precision medicine, announced today that the Department of Anatomical Pathology PathWest Laboratory Medicine will use the company’s Clinical Genomics WorkSpace™ (CGW) platform, the industry’s leading integrated workspace for clinical genomic analytics, classification, interpretation and reporting.
Read Storyby Josh Forsythe, on June 1, 2018
by Josh Forsythe, on May 23, 2018
MAY 24, 2018 -- ST. LOUIS -- PierianDx, the leader in clinical genomics solutions, announced today that it has appointed Michael L. Sanderson as Chief Executive Officer and Director of the Board. In his new role, Sanderson will execute on the company’s strategy to integrate PierianDx’s unique value proposition for molecular labs into the broader precision medicine and healthcare delivery markets.
Read Storyby Josh Forsythe, on May 13, 2018
MAY 14, 2018 -- ST. LOUIS -- PierianDx, the leading clinical genomics technology company that enables precision medicine, announced today that it has executed a distribution agreement with ScienceVision, a leading provider of end-to-end genomic solutions in the Asia Pacific region.
Read Storyby Josh Forsythe, on April 17, 2018
PierianDx, the leading genomics technology companythat enables precision medicine,announced today a strategic partnership with RTI International to help solve the problem of translating complex genomic data into actionable clinical insight to advance precision medicine. The partnership includes investment and collaboration on product, service and market expansion.
Read Storyby Josh Forsythe, on April 13, 2018
One of America’s greatest inventors, Thomas Edison, didn’t invent the light bulb. The technology already existed, and he merely accelerated its adoption by optimizing it and later developing a system to deliver it. He knew that going from the spark of one light bulb filament to powering homes and factories would require not only the right technology but the right approach.
Read Storyby Josh Forsythe, on April 12, 2018
PierianDx, the leading genomics technology company that enables precision medicine, announced today at the annual meeting of the American College of Medical Genetics and Genomics (ACMG) a series of enhanced germline testing features for the company’s enterprise informatics software platform.
Read Storyby Josh Forsythe, on April 11, 2018
PierianDx named Chris Callahan as the new Chief Commercial Officer to accelerate adoption and expansion of the company’s enterprise informatics software platform, the Clinical Genomics WorkSpace (CGW). Chris will report to PierianDx CEO Rakesh Nagarjan, M.D., Ph.D., and oversee customer success, sales, marketing, and business development.
Read Storyby Josh Forsythe, on April 10, 2018
Cardiovascular disease causes more deaths worldwide than any other disease. In 2015 alone, nearly 18 million people died from cardiovascular disease. And according to the World Health Organization, most cardiovascular disease can be prevented or successfully treated by eliminating risk factors such as smoking and tobacco use, obesity, and physical inactivity. [1]
Read Story
6 City Place
Creve Coeur, MO 63141
314-628-0035
